These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 30920961

  • 1. Screening for NTRK-rearranged Tumors Using Immunohistochemistry: Comparison of 2 Different pan-TRK Clones in Melanoma Samples.
    Bourhis A, Redoulez G, Quintin-Roué I, Marcorelles P, Uguen A.
    Appl Immunohistochem Mol Morphol; 2020 Mar; 28(3):194-196. PubMed ID: 30920961
    [Abstract] [Full Text] [Related]

  • 2. Detection of NTRK fusions in glioblastoma: fluorescent in situ hybridisation is more useful than pan-TRK immunohistochemistry as a screening tool prior to RNA sequencing.
    Bourhis A, Caumont C, Quintin-Roué I, Magro E, Dissaux G, Remoué A, Le Noac'h P, Douet-Guilbert N, Seizeur R, Tyulyandina A, Schick U, Merlio JP, Marcorelles P, Cappellen D, Uguen A.
    Pathology; 2022 Feb; 54(1):55-62. PubMed ID: 34518039
    [Abstract] [Full Text] [Related]

  • 3. EPR17341 and A7H6R pan-TRK Immunohistochemistry Result in Highly Different Staining Patterns in a Series of Salivary Gland Tumors.
    Guibourg B, Cloarec E, Conan-Charlet V, Quintin-Roué I, Grippari JL, Le Flahec G, Marcorelles P, Uguen A.
    Appl Immunohistochem Mol Morphol; 2020 Oct; 28(9):719-724. PubMed ID: 32187023
    [Abstract] [Full Text] [Related]

  • 4. Fluorescent In Situ Hybridization Must be Preferred to pan-TRK Immunohistochemistry to Diagnose NTRK3-rearranged Gastrointestinal Stromal Tumors (GIST).
    Castillon M, Kammerer-Jacquet SF, Cariou M, Costa S, Conq G, Samaison L, Douet-Guilbert N, Marcorelles P, Doucet L, Uguen A.
    Appl Immunohistochem Mol Morphol; 2021 Sep 01; 29(8):626-634. PubMed ID: 33758144
    [Abstract] [Full Text] [Related]

  • 5. A systematic comparison of pan-Trk immunohistochemistry assays among multiple cancer types.
    Haberecker M, Töpfer A, Melega F, Moch H, Pauli C.
    Histopathology; 2023 Jun 01; 82(7):1003-1012. PubMed ID: 36759438
    [Abstract] [Full Text] [Related]

  • 6. Detection of NTRK1/3 Rearrangements in Papillary Thyroid Carcinoma Using Immunohistochemistry, Fluorescent In Situ Hybridization, and Next-Generation Sequencing.
    Lee YC, Chen JY, Huang CJ, Chen HS, Yang AH, Hang JF.
    Endocr Pathol; 2020 Dec 01; 31(4):348-358. PubMed ID: 32880785
    [Abstract] [Full Text] [Related]

  • 7. Pan-Trk Immunohistochemistry Is an Efficient and Reliable Screen for the Detection of NTRK Fusions.
    Hechtman JF, Benayed R, Hyman DM, Drilon A, Zehir A, Frosina D, Arcila ME, Dogan S, Klimstra DS, Ladanyi M, Jungbluth AA.
    Am J Surg Pathol; 2017 Nov 01; 41(11):1547-1551. PubMed ID: 28719467
    [Abstract] [Full Text] [Related]

  • 8. Broadening the spectrum of NTRK rearranged mesenchymal tumors and usefulness of pan-TRK immunohistochemistry for identification of NTRK fusions.
    Brčić I, Godschachner TM, Bergovec M, Igrec J, Till H, Lackner H, Scheipl S, Kashofer K, Brodowicz T, Leithner A, Szkandera J, Liegl-Atzwanger B.
    Mod Pathol; 2021 Feb 01; 34(2):396-407. PubMed ID: 32860002
    [Abstract] [Full Text] [Related]

  • 9. Limited Accuracy of Pan-Trk Immunohistochemistry Screening for NTRK Rearrangements in Follicular-Derived Thyroid Carcinoma.
    Macerola E, Proietti A, Poma AM, Vignali P, Sparavelli R, Ginori A, Basolo A, Elisei R, Santini F, Basolo F.
    Int J Mol Sci; 2022 Jul 05; 23(13):. PubMed ID: 35806472
    [Abstract] [Full Text] [Related]

  • 10. Pan-Trk Immunohistochemistry Identifies NTRK Rearrangements in Pediatric Mesenchymal Tumors.
    Rudzinski ER, Lockwood CM, Stohr BA, Vargas SO, Sheridan R, Black JO, Rajaram V, Laetsch TW, Davis JL.
    Am J Surg Pathol; 2018 Jul 05; 42(7):927-935. PubMed ID: 29683818
    [Abstract] [Full Text] [Related]

  • 11. Clinicopathological features and immunohistochemical utility of NTRK-, ALK-, and ROS1-rearranged papillary thyroid carcinomas and anaplastic thyroid carcinomas.
    Nozaki Y, Yamamoto H, Iwasaki T, Sato M, Jiromaru R, Hongo T, Yasumatsu R, Oda Y.
    Hum Pathol; 2020 Dec 05; 106():82-92. PubMed ID: 32980422
    [Abstract] [Full Text] [Related]

  • 12. The sensitivity of pan-TRK immunohistochemistry in solid tumours: A meta-analysis.
    Hondelink LM, Schrader AMR, Asri Aghmuni G, Solleveld-Westerink N, Cleton-Jansen AM, van Egmond D, Boot A, Ouahoud S, Khalifa MN, Wai Lam S, Morreau H, Bovee JVMG, van Wezel T, Cohen D.
    Eur J Cancer; 2022 Sep 05; 173():229-237. PubMed ID: 35933886
    [Abstract] [Full Text] [Related]

  • 13. Pan-tumor screening for NTRK gene fusions using pan-TRK immunohistochemistry and RNA NGS fusion panel testing.
    Koehne de González A, Mansukhani MM, Fernandes H, Hsiao SJ.
    Cancer Genet; 2022 Apr 05; 262-263():47-52. PubMed ID: 35007853
    [Abstract] [Full Text] [Related]

  • 14. NTRK Fusions Define a Novel Uterine Sarcoma Subtype With Features of Fibrosarcoma.
    Chiang S, Cotzia P, Hyman DM, Drilon A, Tap WD, Zhang L, Hechtman JF, Frosina D, Jungbluth AA, Murali R, Park KJ, Soslow RA, Oliva E, Iafrate AJ, Benayed R, Ladanyi M, Antonescu CR.
    Am J Surg Pathol; 2018 Jun 05; 42(6):791-798. PubMed ID: 29553955
    [Abstract] [Full Text] [Related]

  • 15. Pan-TRK immunohistochemistry in gynaecological mesenchymal tumours: diagnostic implications and pitfalls.
    Moura MS, Costa J, Velasco V, Kommoss F, Oliva E, Le Loarer F, McCluggage WG, Razack R, Treilleux I, Mills A, Longacre T, Devouassoux-Shisheboran M, Hostein I, Azmani R, Blanchard L, Hartog C, Soubeyran I, Khalifa E, Croce S.
    Histopathology; 2024 Feb 05; 84(3):451-462. PubMed ID: 37988282
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Elaboration of NTRK-rearranged colorectal cancer: Integration of immunoreactivity pattern, cytogenetic identity, and rearrangement variant.
    Wu S, Liu Y, Shi X, Zhou W, Zeng X.
    Dig Liver Dis; 2023 Dec 05; 55(12):1757-1764. PubMed ID: 37142453
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.